Friday, January 10, 2020 3:04:27 PM
and we may hear news next week that those remaining release tests passed with flying colors...then what?
Then that would be good for 2 weeks of silence thereafter. Kenny allows the suspense to build up again. Afterwards his best PR pump play is to trot out Medpace or the CRO again. Talk about all the anticipated clinical activity to come. That takes care of the month of Jan.
Start Feb by saying they are still putting the mythical IND together. Good for another 2 weeks of silence thereafter. Time for Lohr to make a guest appearance in a PR pump again? That's only good for 1 week of silence thereafter.
Now we're into Mar, and busy working on "pay as you go" funding. Commonly called another private placement. Or does that come earlier? A few more fluffy PR pumps after that and the big moment has arrived... closing in on 15-Apr again!
Then that would be good for 2 weeks of silence thereafter. Kenny allows the suspense to build up again. Afterwards his best PR pump play is to trot out Medpace or the CRO again. Talk about all the anticipated clinical activity to come. That takes care of the month of Jan.
Start Feb by saying they are still putting the mythical IND together. Good for another 2 weeks of silence thereafter. Time for Lohr to make a guest appearance in a PR pump again? That's only good for 1 week of silence thereafter.
Now we're into Mar, and busy working on "pay as you go" funding. Commonly called another private placement. Or does that come earlier? A few more fluffy PR pumps after that and the big moment has arrived... closing in on 15-Apr again!
The Jewel of the Mind is Colored with the Hue of what it Imagines
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
